Mirati Therapeutics, Inc. (MRTX)
After hours:
Chart Events
Performance Outlook
| Previous Close | 38.77 |
| Open | 38.49 |
| Bid | 38.84 x 800 |
| Ask | 38.98 x 800 |
| Day's Range | 36.92 - 39.19 |
| 52 Week Range | 32.96 - 101.30 |
| Volume | |
| Avg. Volume | 1,162,342 |
| Market Cap | 2.269B |
| Beta (5Y Monthly) | 1.04 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -12.45 |
| Earnings Date | May 02, 2023 - May 08, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 70.87 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for MRTX
Related Research
- Mirati Therapeutics, Inc.Daily – Vickers Top Buyers & Sellers for 01/19/2022The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.RatingFair ValueEconomic Moatlast yearArgus Research
- PR Newswire
Mirati Therapeutics to Participate at the Barclays Global Healthcare Conference
Mirati Therapeutics, Inc. (NASDAQ: MRTX), a commercial stage biotechnology company, will participate at the Barclays Global Healthcare Conference on March 14 at 6:00 a.m. P.T. / 9:00 a.m. E.T. Ben Hickey, chief commercial officer, and Alan Sandler, chief medical officer, will represent the company in a fireside chat at the conference.
- Simply Wall St.
Analyst Forecasts Just Became More Bearish On Mirati Therapeutics, Inc. (NASDAQ:MRTX)
One thing we could say about the analysts on Mirati Therapeutics, Inc. ( NASDAQ:MRTX ) - they aren't optimistic, having...
- Insider Monkey
Mirati Therapeutics, Inc. (NASDAQ:MRTX) Q4 2022 Earnings Call Transcript
Mirati Therapeutics, Inc. (NASDAQ:MRTX) Q4 2022 Earnings Call Transcript February 28, 2023 Operator: Good afternoon and welcome to the Mirati Therapeutics Fourth Quarter 2022 Earnings Call. My name is Cynthia and I’ll be the operator for today’s call. It is my pleasure to introduce Ryan Asay, Vice President of Corporate Affairs at Mirati. Ryan, you […]
